{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:25:25Z","timestamp":1792571125275,"version":"4.5.0"},"reference-count":53,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:p>We conducted a Mendelian randomization analysis to differentiate associations of four glycemic indicators with a broad range of atherosclerotic and thrombotic diseases. Independent genetic variants associated with fasting glucose (FG), 2 h glucose after an oral glucose challenge (2hGlu), fasting insulin (FI), and glycated hemoglobin (HbA1c) at the genome-wide significance threshold were used as instrumental variables. Summary-level data for 12 atherosclerotic and 4 thrombotic outcomes were obtained from large genetic consortia and the FinnGen and UK Biobank studies. Higher levels of genetically predicted glycemic traits were consistently associated with increased risk of coronary atherosclerosis\u2013related diseases and symptoms. Genetically predicted glycemic traits except HbA1c showed positive associations with peripheral artery disease risk. Genetically predicted FI levels were positively associated with risk of ischemic stroke and chronic kidney disease. Genetically predicted FG and 2hGlu were positively associated with risk of large artery stroke. Genetically predicted 2hGlu levels showed positive associations with risk of small vessel stroke. Higher levels of genetically predicted glycemic traits were not associated with increased risk of thrombotic outcomes. Most associations for genetically predicted levels of 2hGlu and FI remained after adjustment for other glycemic traits. Increase in glycemic status appears to increase risks of coronary and peripheral artery atherosclerosis but not thrombosis.<\/jats:p>","DOI":"10.2337\/db21-0905","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T09:34:20Z","timestamp":1651484060000},"page":"2222-2232","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":23,"title":["Differentiating Associations of Glycemic Traits With Atherosclerotic and Thrombotic Outcomes: Mendelian Randomization Investigation"],"prefix":"10.2337","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-5627","authenticated-orcid":false,"given":"Shuai","family":"Yuan","sequence":"first","affiliation":[{"name":"1Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Mason","sequence":"additional","affiliation":[{"name":"2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[{"name":"3MRC Biostatistics Unit, University of Cambridge, Cambridge, U.K"},{"name":"4Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-0341","authenticated-orcid":false,"given":"Susanna C.","family":"Larsson","sequence":"additional","affiliation":[{"name":"1Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"5Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"2022092018595008700_B1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"2022092018595008700_B2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"2022092018595008700_B3","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"2022092018595008700_B4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"2022092018595008700_B5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","article-title":"Diabetes mellitus and thrombosis","volume":"129","author":"Vazzana","year":"2012","journal-title":"Thromb Res"},{"key":"2022092018595008700_B6","doi-asserted-by":"crossref","first-page":"e007858","DOI":"10.1161\/JAHA.117.007858","article-title":"Relationship between glycated hemoglobin and stroke risk: a systematic review and meta-analysis","volume":"7","author":"Mitsios","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2022092018595008700_B7","doi-asserted-by":"crossref","DOI":"10.1201\/b18084","volume-title":"Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation","author":"Burgess","year":"2015"},{"key":"2022092018595008700_B8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10654-021-00726-8","article-title":"Are Mendelian randomization investigations immune from bias due to reverse causation?","volume":"36","author":"Burgess","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"2022092018595008700_B9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/dc18-0289","article-title":"The impact of glycated hemoglobin (HbA1c) on cardiovascular disease risk: a Mendelian randomization study using UK Biobank","volume":"41","author":"Au Yeung","year":"2018","journal-title":"Diabetes Care"},{"key":"2022092018595008700_B10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/dc18-1712","article-title":"Mendelian randomization analysis of hemoglobin A1c as a risk factor for coronary artery disease","volume":"42","author":"Leong","year":"2019","journal-title":"Diabetes Care"},{"key":"2022092018595008700_B11","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-017-4396-y","article-title":"The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study","volume":"60","author":"Xu","year":"2017","journal-title":"Diabetologia"},{"key":"2022092018595008700_B12","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1007\/s00125-021-05537-w","article-title":"Assessing the linear and non-linear association of HbA1c with cardiovascular disease: a Mendelian randomisation study","volume":"64","author":"Luo","year":"2021","journal-title":"Diabetologia"},{"key":"2022092018595008700_B13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/genes12101644","article-title":"Genetically predicted type 2 diabetes mellitus liability, glycated hemoglobin and cardiovascular diseases: a wide-angled Mendelian randomization study","volume":"12","author":"Liu","year":"2021","journal-title":"Genes (Basel)"},{"key":"2022092018595008700_B14","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1212\/WNL.0000000000011555","article-title":"Diabetes mellitus, glycemic traits, and cerebrovascular disease: a Mendelian randomization study","volume":"96","author":"Georgakis","year":"2021","journal-title":"Neurology"},{"key":"2022092018595008700_B15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1007\/s00125-021-05436-0","article-title":"Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis","volume":"64","author":"Benn","year":"2021","journal-title":"Diabetologia"},{"key":"2022092018595008700_B16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1212\/WNL.0000000000004173","article-title":"Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes: Mendelian randomization study","volume":"89","author":"Larsson","year":"2017","journal-title":"Neurology"},{"key":"2022092018595008700_B17","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s00125-020-05163-y","article-title":"Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: a bi-directional Mendelian randomisation study","volume":"63","author":"Zhao","year":"2020","journal-title":"Diabetologia"},{"key":"2022092018595008700_B18","doi-asserted-by":"crossref","first-page":"e001395","DOI":"10.1136\/bmjdrc-2020-001395","article-title":"Impaired fasting glucose and development of chronic kidney disease in non-diabetic population: a Mendelian randomization study","volume":"8","author":"Kim","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022092018595008700_B19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc19-1850","article-title":"Impact of glucose level on micro- and macrovascular disease in the general population: a Mendelian randomization study","volume":"43","author":"Emanuelsson","year":"2020","journal-title":"Diabetes Care"},{"key":"2022092018595008700_B20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat Genet"},{"key":"2022092018595008700_B21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"2022092018595008700_B22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"van der Harst","year":"2018","journal-title":"Circ Res"},{"key":"2022092018595008700_B23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"2022092018595008700_B24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41588-020-00725-7","article-title":"Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors","volume":"52","author":"Bakker","year":"2020","journal-title":"Nat Genet"},{"key":"2022092018595008700_B25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"key":"2022092018595008700_B26","unstructured":"R5 release of FinnGen consortium genome-wide association analysis data [article online], 2021. Available from https:\/\/finngen.gitbook.io\/documentation\/. Accessed July 6th 2021"},{"key":"2022092018595008700_B27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2022092018595008700_B28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2022092018595008700_B29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","article-title":"A robust and efficient method for Mendelian randomization with hundreds of genetic variants","volume":"11","author":"Burgess","year":"2020","journal-title":"Nat Commun"},{"key":"2022092018595008700_B30","doi-asserted-by":"crossref","first-page":"e0185083","DOI":"10.1371\/journal.pone.0185083","article-title":"Red blood cell distribution width: genetic evidence for aging pathways in 116,666 volunteers","volume":"12","author":"Pilling","year":"2017","journal-title":"PLoS One"},{"key":"2022092018595008700_B31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/cvr\/cvz156","article-title":"Red blood cell dysfunction: a new player in cardiovascular disease","volume":"115","author":"Pernow","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2022092018595008700_B32","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"2022092018595008700_B33","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2022092018595008700_B34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc05-1902","article-title":"Blood glucose and coronary artery disease in nondiabetic patients","volume":"29","author":"Nielson","year":"2006","journal-title":"Diabetes Care"},{"key":"2022092018595008700_B35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.diabres.2013.10.011","article-title":"Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity","volume":"102","author":"Ashraf","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"2022092018595008700_B36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2018.04.042","article-title":"Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study","volume":"274","author":"Ding","year":"2018","journal-title":"Atherosclerosis"},{"key":"2022092018595008700_B37","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000140738.94047.55","article-title":"Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study","volume":"35","author":"Tanne","year":"2004","journal-title":"Stroke"},{"key":"2022092018595008700_B38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.annepidem.2017.12.003","article-title":"Diabetes-related factors and abdominal aortic aneurysm events: the Atherosclerotic Risk in Communities Study","volume":"28","author":"Kubota","year":"2018","journal-title":"Ann Epidemiol"},{"key":"2022092018595008700_B39","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/euhj.2001.3113","article-title":"Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose","volume":"23","author":"Qiao","year":"2002","journal-title":"Eur Heart J"},{"key":"2022092018595008700_B40","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Diabetes Care"},{"key":"2022092018595008700_B41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2014.11.003","article-title":"Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis","volume":"135","author":"Bai","year":"2015","journal-title":"Thromb Res"},{"key":"2022092018595008700_B42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjh.15599","article-title":"Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study","volume":"184","author":"Li-Gao","year":"2019","journal-title":"Br J Haematol"},{"key":"2022092018595008700_B43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jth.12498","article-title":"Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Troms\u00f8 study","volume":"12","author":"Lerstad","year":"2014","journal-title":"J Thromb Haemost"},{"key":"2022092018595008700_B44","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"2022092018595008700_B45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2047487319878373","article-title":"The link between diabetes and atherosclerosis","volume":"26","author":"La Sala","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2022092018595008700_B46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.107.151852","article-title":"Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells","volume":"101","author":"Lavrentyev","year":"2007","journal-title":"Circ Res"},{"key":"2022092018595008700_B47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/HJH.0000000000002210","article-title":"The impact of glycated hemoglobin on risk of hypertension: a Mendelian randomization study using UK Biobank","volume":"38","author":"Au Yeung","year":"2020","journal-title":"J Hypertens"},{"key":"2022092018595008700_B48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejvs.2009.10.014","article-title":"Diabetes and the abdominal aortic aneurysm","volume":"39","author":"Shantikumar","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022092018595008700_B49","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/cvr\/cvy174","article-title":"Diabetes and aortic aneurysm: current state of the art","volume":"114","author":"Raffort","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022092018595008700_B50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","article-title":"Diabetes mellitus and venous thromboembolism: a systematic review and meta-analysis","volume":"111","author":"Bell","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"2022092018595008700_B51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/jth.15168","article-title":"Overall and abdominal obesity in relation to venous thromboembolism","volume":"19","author":"Yuan","year":"2021","journal-title":"J Thromb Haemost"},{"key":"2022092018595008700_B52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2022092018595008700_B53","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ije\/dyz234","article-title":"Commentary: Mendelian randomization with multiple exposures: the importance of thinking about time","volume":"49","author":"Labrecque","year":"2020","journal-title":"Int J Epidemiol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/71\/10\/2222\/688312\/db210905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/71\/10\/2222\/688312\/db210905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:44:24Z","timestamp":1667393064000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/71\/10\/2222\/146862\/Differentiating-Associations-of-Glycemic-Traits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5,2]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db21-0905","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.19607241.v1","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.19607241","asserted-by":"object"}]},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,2]]}}}